Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label follow-up of lacosamide monotherapy after SP0994
2015-001549-96Phase 3Completed
- Sponsor
- UCB
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lacosamide in epilepsy, Focal Onset Epilepsy and Epilepsy with generalized tonic-clonic seizures (GTCS), sponsored by UCB. Primary endpoint: Number of adverse events. Started Sep 2015; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsyFocal Onset EpilepsyEpilepsy with generalized tonic-clonic seizures (GTCS)
Beyond the preview
Go deeper on 2015-001549-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001549-96.